TETRALOGIC PHARMACEUTICALS CORP Restructuring Charges
TETRALOGIC PHARMACEUTICALS CORP reported Restructuring Charges of $1.46 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2016-11-03
- TETRALOGIC PHARMACEUTICALS CORP restructuring charges for the quarter ending 2016-09-30 was $1.46M.
- TETRALOGIC PHARMACEUTICALS CORP restructuring charges for the quarter ending 2016-06-30 was $28.87K.
- TETRALOGIC PHARMACEUTICALS CORP restructuring charges for the quarter ending 2016-03-31 was $2.01M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month |
|---|---|---|---|
| 2016-09-30 | $1.46M 10-Q · filed 2016-11-03 | $1.49M derived: sum of 2 quarters · filed 2016-11-03 | $3.50M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $28.87K 10-Q · filed 2016-08-11 | $2.04M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $2.01M 10-Q · filed 2016-05-04 |